STAT3 and gastric cancer: Our findings suggest that bile reflux can promote gastric carcinogenesis through the activation of the IL‐6/JAK1/STAT3 pro‐inflammatory signaling pathway and that STAT3 inhibition can alleviate this carcinogenic effect, thus providing an alternative strategy for the prevention of gastric cancer associated with bile reflux.